Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
PHIO Quote, Financials, Valuation and Earnings
Last price:
$2.41
Seasonality move
:
-21.57%
Day range:
$2.36 - $2.43
52-week range:
$0.97 - $9.79
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.96x
Volume:
64.2K
Avg. volume:
509.2K
1-year change:
-48.48%
Market cap:
$11.7M
Revenue:
--
EPS (TTM):
-$35.38
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.7M | $8.9M | $7M | $6.3M | $3.6M | |
| Selling, General & Admin | $5.1M | $4.6M | $4.5M | $4.4M | $3.7M | |
| Other Inc / (Exp) | -- | $224K | -$18K | -$120K | $6K | |
| Operating Expenses | $8.8M | $13.5M | $11.5M | $10.7M | $7.4M | |
| Operating Income | -$8.8M | -$13.5M | -$11.5M | -$10.7M | -$7.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$8.8M | -$13.3M | -$11.5M | -$10.8M | -$7.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$8.8M | -$13.3M | -$11.5M | -$10.8M | -$7.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$8.8M | -$13.3M | -$11.5M | -$10.8M | -$7.2M | |
| Basic EPS (Cont. Ops) | -$207.36 | -$111.83 | -$90.90 | -$46.76 | -$9.08 | |
| Diluted EPS (Cont. Ops) | -$207.36 | -$111.83 | -$90.90 | -$46.76 | -$9.08 | |
| Weighted Average Basic Share | $42.5K | $118.9K | $126.3K | $231.5K | $787.5K | |
| Weighted Average Diluted Share | $42.5K | $118.9K | $126.3K | $231.5K | $787.5K | |
| EBITDA | -$8.7M | -$13.3M | -$11.3M | -$10.5M | -$7.4M | |
| EBIT | -$8.8M | -$13.5M | -$11.5M | -$10.7M | -$7.4M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$8.8M | -$13.5M | -$11.5M | -$10.7M | -$7.4M | |
| Operating Income (Adjusted) | -$8.8M | -$13.5M | -$11.5M | -$10.7M | -$7.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.4M | $1.6M | $2.1M | $1.1M | $886K | |
| Selling, General & Admin | $1.2M | $1.1M | $1.5M | $1.1M | $986K | |
| Other Inc / (Exp) | $231K | -$2K | -- | $2K | -$22K | |
| Operating Expenses | $3.6M | $2.6M | $3.6M | $2.2M | $1.9M | |
| Operating Income | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Basic EPS (Cont. Ops) | -$34.56 | -$21.06 | -$28.35 | -$0.47 | -$0.41 | |
| Diluted EPS (Cont. Ops) | -$34.56 | -$21.06 | -$28.35 | -$0.47 | -$0.41 | |
| Weighted Average Basic Share | $98.9K | $125.6K | $126.9K | $4.6M | $4.3M | |
| Weighted Average Diluted Share | $98.9K | $125.6K | $126.9K | $4.6M | $4.3M | |
| EBITDA | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| EBIT | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Operating Income (Adjusted) | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.9M | $8M | $7.6M | $5.3M | $3.4M | |
| Selling, General & Admin | $5.1M | $4.5M | $4.9M | $4M | $3.7M | |
| Other Inc / (Exp) | $231K | -$9K | -$16K | -$118K | -$71K | |
| Operating Expenses | $10.1M | $12.5M | $12.4M | $9.3M | $7.1M | |
| Operating Income | -$10.1M | -$12.5M | -$12.4M | -$9.3M | -$7.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$9.9M | -$12.5M | -$12.4M | -$9.4M | -$6.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$9.9M | -$12.5M | -$12.4M | -$9.4M | -$6.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.9M | -$12.5M | -$12.4M | -$9.4M | -$6.8M | |
| Basic EPS (Cont. Ops) | -$158.76 | -$100.49 | -$98.19 | -$131.63 | -$35.38 | |
| Diluted EPS (Cont. Ops) | -$158.76 | -$100.49 | -$98.19 | -$131.63 | -$35.38 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$10M | -$12.3M | -$12.2M | -$9.1M | -$7M | |
| EBIT | -$10.1M | -$12.5M | -$12.4M | -$9.3M | -$7.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$10.1M | -$12.5M | -$12.4M | -$9.3M | -$7.1M | |
| Operating Income (Adjusted) | -$10.1M | -$12.5M | -$12.4M | -$9.3M | -$7.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.4M | $1.6M | $2.1M | $1.1M | $886K | |
| Selling, General & Admin | $1.2M | $1.1M | $1.5M | $1.1M | $986K | |
| Other Inc / (Exp) | $231K | -$2K | -- | $2K | -$22K | |
| Operating Expenses | $3.6M | $2.6M | $3.6M | $2.2M | $1.9M | |
| Operating Income | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Basic EPS (Cont. Ops) | -$34.56 | -$21.06 | -$28.35 | -$0.47 | -$0.41 | |
| Diluted EPS (Cont. Ops) | -$34.56 | -$21.06 | -$28.35 | -$0.47 | -$0.41 | |
| Weighted Average Basic Share | $98.9K | $125.6K | $126.9K | $4.6M | $4.3M | |
| Weighted Average Diluted Share | $98.9K | $125.6K | $126.9K | $4.6M | $4.3M | |
| EBITDA | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| EBIT | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Operating Income (Adjusted) | -$3.6M | -$2.6M | -$3.6M | -$2.2M | -$1.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $14.2M | $24.1M | $11.8M | $8.5M | $5.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $870K | $620K | $615K | $832K | $354K | |
| Total Current Assets | $15.2M | $24.7M | $12.4M | $9.3M | $5.7M | |
| Property Plant And Equipment | $557K | $416K | $344K | $39K | $2K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $18K | $27K | $24K | $3K | -- | |
| Total Assets | $15.7M | $25.2M | $12.8M | $9.4M | $5.7M | |
| Accounts Payable | $728K | $283K | $779K | $657K | $253K | |
| Accrued Expenses | $630K | $2.1M | $617K | $720K | $731K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $116K | $125K | $135K | $35K | -- | |
| Other Current Liabilities | $104K | -- | -- | -- | -- | |
| Total Current Liabilities | $2.2M | $3.1M | $1.9M | $1.6M | $1M | |
| Long-Term Debt | $231K | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.7M | $3.2M | $2M | $1.6M | $1M | |
| Common Stock | $1K | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $13M | $21.9M | $10.8M | $7.7M | $4.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $13M | $21.9M | $10.8M | $7.7M | $4.7M | |
| Total Liabilities and Equity | $15.7M | $25.2M | $12.8M | $9.4M | $5.7M | |
| Cash and Short Terms | $14.2M | $24.1M | $11.8M | $8.5M | $5.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $32.7M | $20.5M | $9M | $6.5M | $13.3M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $577K | $1.2M | $319K | $373K | $158K | |
| Total Current Assets | $33.3M | $21.7M | $9.4M | $6.8M | $13.4M | |
| Property Plant And Equipment | $516K | $468K | $297K | $2K | $4K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $18K | $27K | $6K | $3K | -- | |
| Total Assets | $33.9M | $22.2M | $9.7M | $6.9M | $13.4M | |
| Accounts Payable | $615K | $329K | $902K | $320K | $427K | |
| Accrued Expenses | $1.5M | $2.1M | $1.4M | $929K | $843K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $118K | $127K | $138K | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.2M | $2.6M | $2.4M | $1.2M | $1.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.5M | $2.7M | $2.4M | $1.2M | $1.3M | |
| Common Stock | $1K | $1K | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -$2K | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $31.4M | $19.5M | $7.3M | $5.6M | $12.2M | |
| Total Liabilities and Equity | $33.9M | $22.2M | $9.7M | $6.9M | $13.4M | |
| Cash and Short Terms | $32.7M | $20.5M | $9M | $6.5M | $13.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$8.8M | -$13.3M | -$11.5M | -$10.8M | -$7.2M | |
| Depreciation & Amoritzation | $72K | $192K | $193K | $184K | $35K | |
| Stock-Based Compensation | $136K | $480K | $414K | $303K | $147K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$8.8M | -$11.9M | -$12.1M | -$10.7M | -$7.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$19K | -$51K | -$121K | -$5K | $8K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $231K | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$27K | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$15K | -- | -- | -$13K | -$1K | |
| Other Financing Activities | -$2K | -$1K | -$28K | -$26K | -$5K | |
| Cash From Financing | $16.1M | $21.7M | -$26K | $7.4M | $4M | |
| Beginning Cash (CF) | $7M | $14.3M | $24.1M | $11.8M | $8.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.3M | $9.8M | -$12.3M | -$3.3M | -$3.1M | |
| Ending Cash (CF) | $14.3M | $24.1M | $11.8M | $8.5M | $5.4M | |
| Levered Free Cash Flow | -$8.8M | -$11.9M | -$12.3M | -$10.8M | -$7.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Depreciation & Amoritzation | $18K | $52K | $47K | $34K | -- | |
| Stock-Based Compensation | $67K | $186K | $111K | $32K | $43K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$3.3M | -$3.5M | -$2.7M | -$2M | -$1.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6K | -$104K | -- | -- | -$2K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$13K | -- | -- | |
| Other Financing Activities | -- | -$25K | -$25K | -$4K | -- | |
| Cash From Financing | $21.7M | -$25K | -$38K | -$4K | $9.2M | |
| Beginning Cash (CF) | $14.3M | $24.1M | $11.8M | $8.5M | $5.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18.5M | -$3.6M | -$2.7M | -$2M | $7.9M | |
| Ending Cash (CF) | $32.7M | $20.5M | $9.1M | $6.5M | $13.3M | |
| Levered Free Cash Flow | -$3.3M | -$3.6M | -$2.7M | -$2M | -$1.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$9.9M | -$12.5M | -$12.4M | -$9.4M | -$6.8M | |
| Depreciation & Amoritzation | $72K | $226K | $188K | $171K | $1K | |
| Stock-Based Compensation | $160K | $599K | $339K | $224K | $158K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$9.9M | -$12.1M | -$11.4M | -$10.1M | -$6.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$15K | -$149K | -- | -$5K | $6K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$13K | -- | -- | |
| Other Financing Activities | -- | -- | -$28K | -$5K | -- | |
| Cash From Financing | $29.3M | -$26K | -$39K | $7.4M | $13.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.4M | -$12.2M | -$11.4M | -$2.6M | $6.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$9.9M | -$12.2M | -$11.4M | -$10.1M | -$6.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.4M | -$2.6M | -$3.6M | -$2.2M | -$1.8M | |
| Depreciation & Amoritzation | $18K | $52K | $47K | $34K | -- | |
| Stock-Based Compensation | $67K | $186K | $111K | $32K | $43K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$3.3M | -$3.5M | -$2.7M | -$2M | -$1.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6K | -$104K | -- | -- | -$2K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$13K | -- | -- | |
| Other Financing Activities | -- | -$25K | -$25K | -$4K | -- | |
| Cash From Financing | $21.7M | -$25K | -$38K | -$4K | $9.2M | |
| Beginning Cash (CF) | $14.3M | $24.1M | $11.8M | $8.5M | $5.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18.5M | -$3.6M | -$2.7M | -$2M | $7.9M | |
| Ending Cash (CF) | $32.7M | $20.5M | $9.1M | $6.5M | $13.3M | |
| Levered Free Cash Flow | -$3.3M | -$3.6M | -$2.7M | -$2M | -$1.3M | |
Get PHIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PHIO
Sector
P/E ratio
--
24.07x
PEG ratio
--
0.00x
P/B ratio
0.96x
1.81x
Price / LTM sales
--
1.67x
Growth Metrics
PHIO
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
--
8.01%
Earnings forecast
--
-$0.20
Profitability
PHIO
Sector
Profitability FY 2025
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Jul
18
Estimated Next Earnings Date
Oct
17
Balance Sheet
PHIO
Sector
Total cash
$13.3M
$35.7M
Short term investments
--
$29.7M
Total assets
$5.7M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
